Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FIGS | ADMA |
|---|---|---|
| Price | $13.63 | $10.11 |
| Change today | ▲ 0.81% | ▲ 4.01% |
| Market cap | $2.26B | $2.26B |
| Return, 3 months | +37.7% | +9.8% |
| Return, year to date | +20.0% | -44.6% |
| Return, 1 year | +93.9% | -28.1% |
| P/E (TTM) | 41.3 | 14.4 |
| P/B | 5.1 | 5.5 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +28.8% | – |
| Net profit growth (YoY) | +299.8% | – |
| Gross margin | 75.2% | – |
| Operating margin | 17.9% | – |
| Net margin | 14.4% | – |
| Return on equity | – | – |
| Analyst target vs. price | +33.1% | +55.0% |
| Analyst buy share | 57% | 67% |
| RSI (14) | 51 | 59 |
| 30-day volatility | 55.3% | 41.2% |
| Max drawdown, 1 year | -46.0% | -62.7% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
